These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9371168)

  • 1. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis.
    Giroir BP; Quint PA; Barton P; Kirsch EA; Kitchen L; Goldstein B; Nelson BJ; Wedel NJ; Carroll SF; Scannon PJ
    Lancet; 1997 Nov; 350(9089):1439-43. PubMed ID: 9371168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.
    Levin M; Quint PA; Goldstein B; Barton P; Bradley JS; Shemie SD; Yeh T; Kim SS; Cafaro DP; Scannon PJ; Giroir BP
    Lancet; 2000 Sep; 356(9234):961-7. PubMed ID: 11041396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia.
    Giroir BP; Scannon PJ; Levin M
    Crit Care Med; 2001 Jul; 29(7 Suppl):S130-5. PubMed ID: 11445748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal/permeability-increasing protein for severe meningococcal sepsis.
    Powell J; Ray M
    Lancet; 1998 Feb; 351(9101):525-6. PubMed ID: 9482479
    [No Abstract]   [Full Text] [Related]  

  • 5. Bactericidal/permeability-increasing protein for severe meningococcal sepsis.
    Schultz H; Csernok E; Gross WL
    Lancet; 1998 Feb; 351(9101):526. PubMed ID: 9482480
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability increasing protein (rBPI21) after liver surgery in rats and humans.
    Wiezer MJ; Langendoen SI; Meijer C; Bauer RJ; White ML; Carroll SF; Meyer S; Thijs LG; van Leeuwen PA
    Shock; 1998 Sep; 10(3):161-6; discussion 167-8. PubMed ID: 9744643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapies for severe meningococcal disease.
    Giroir BP
    Lancet; 1998 Feb; 351(9101):526-8. PubMed ID: 9482481
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant N-terminal fragment of bactericidal/permeability increasing protein (rBPI21) prevents shock-induced microcirculatory alterations in the liver.
    Bauer C; Riemer-Paxian I; Larsen R; Marzi I
    Crit Care Med; 1997 Aug; 25(8):1283-8. PubMed ID: 9267939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of the bactericidal/permeability-increasing protein.
    Levy O
    Expert Opin Investig Drugs; 2002 Feb; 11(2):159-67. PubMed ID: 11829710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restored credibility for sepsis therapeutics?
    Webber D
    Nat Biotechnol; 1998 Dec; 16(13):1303. PubMed ID: 9853597
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of scoring systems in acute meningococcaemia.
    Hachimi-Idrissi S; Corne L; Ramet J
    Eur J Emerg Med; 1998 Jun; 5(2):225-30. PubMed ID: 9846250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteers.
    Bauer RJ; Wedel N; Havrilla N; White M; Cohen A; Carroll SF
    J Clin Pharmacol; 1999 Nov; 39(11):1169-76. PubMed ID: 10579148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in trial parameters.
    Schwieterman WD; Weiss KD; Tiwari J; Siegel JP
    Lancet; 2001 Jan; 357(9252):314. PubMed ID: 11214164
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospective validation of the Glasgow Meningococcal Septicaemia Prognostic Score. Comparison with other scoring methods.
    Riordan FA; Marzouk O; Thomson AP; Sills JA; Hart CA
    Eur J Pediatr; 2002 Oct; 161(10):531-7. PubMed ID: 12297899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal/permeability-increasing protein ameliorates hypercoagulability after hemorrhagic shock.
    Yamashita M
    Thromb Res; 1997 Aug; 87(3):323-9. PubMed ID: 9263399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection.
    Wiezer MJ; Meijer C; Sietses C; Prins HA; Cuesta MA; Beelen RH; Meijer S; van Leeuwen PA
    Ann Surg; 2000 Aug; 232(2):208-15. PubMed ID: 10903599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.